In 1938, Webster reported an investigation on the immunizing properties of phenolized rabies vaccines in Swiss mice. His findings indicated that multiple doses of the majority of the phenolized vaccines tested failed to immunize mice against as little as one intracerebral lethal dose of virus. At the same time he reported the highly immunogenic properties of living tissue-culture virus.
Following this report, studies were initiated in these laboratories on the methods employed in the preparation of human and veterinary rabies vaccines, using Swiss-W mice as test animals. Along with the studies on killed vaccines, it seemed desirable to determine the quantity of our living virus that was required to immunize mice effectively against intracerebrally injected doses of virus. It also seemed of interest to compare this strain with other known fixed virus strains. The results of these experiments form the basis for this report.
There is ample evidence in the literature to suggest that fixed virus strains differ in their immunogenic properties; but few attempts have been made to compare any two strains on the basis of the virus content (either virulent or non-virulent) per vaccinating dose. The most comprehensive investigations along these lines have been conducted by workers at the Pasteur Institute of India, Kasauli (Cunningham et al., 1934 and Shortt et al., 1934 and 1937 who prepared and tested killed vaccines from various strains of fixed virus, and concluded from their experimental data that, of the strains tested, the Pasteur virus (Paris) was the most actively antigenic. However, animals other than mice were employed.
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Since the completion of the major portion of our investigation, Habel (1940) has reported that fixed virus strains differ considerably in their resistance to phenol and that phenolized vaccines prepared from phenol-resistant strains are more antigenic for mice than those produced from strains more readily killed by phenol.
EXPERIMENTAL METHODS
Seventeen strains of fixed rabies virus were employed in this study. Thirteen strains were supplied by the National Institute of Health through the courtesy of Dr. Harrison and Dr. Habel. These were sent to us in glycerol-salt solution in either rabbit brain or mouse brain under code numbers S-1 to S-13 inclusive. These strains were among those employed by Dr. Habel in his own studies and were proven to be authentic rabies viruses by in vitro neutralization tests with antirabic immune serum prepared from a single strain. Upon receipt of the strains, five of them were selected at random and again tested with an antirabic serum prepared in this laboratory.
After completion of the investigation, the strain numbers S-1 to S-13 were decoded; their identities are given in The methods employed in the investigation are similar to those reported by Webster (1939) and Casals (1940) . Swiss-W mice from our own colony 21 to 22 days old have been used, both for titration of the viruses and for vaccination with the lving virus.
Fresh mouse brain in either the second or third passage was used as a source of virus, except in the case of strain S-14 which was rabbit brain virus. Animals moribund with rabies were sacrificed, their brains removed, ground finely with alundum and diluted to 10 per cent with either hormone broth or 10 per cent horse serum in distilled water. The ground suspension of virus tissue was then centrifuged for 10 minutes at approximately 2000 r.p.m. to throw down the heavy particles and the supernatant (regarded as the 10-1 dilution) removed for further dilution. Three groups of mice, 25 to 30 per group were injected intraperitoneally with 0.5 ml. of the 10-2, 10-3 and 10-4 dilutions respectively. At the same time, titration of the virus content of the vaccinating dose was determined by injecting 4 to 6 mice intracerebrally with 0.03 ml. of the 10-4 to 10-8 dilutions inclusive. All intracerebral injections were done under ether anesthesia. The highest dilution of the virus killing one-half or more of the injected mice was regarded as the minimum lethal dose (M.L.D.). From the figures thus obtained, calculations were made of the approximate number of intracerebral M.L.D.'s contained in each vaccinating dose. A number of the mice injected intraperitoneally succumbed to rabies, depending on the amount of virus injected and the strain employed. Three weeks later the surviving animals were tested for immunity by the intracerebral injection of appropriate dilutions of the homologous virus. Normal mice set aside at the same time that the test animals were vaccinated, served as controls for titration of the challenge virus. The intracerebrally injected mice were then observed daily for a period of 21 days and deaths preceded by typical symptoms of rabies were recorded.
398
As in the previous titrations of virus content of the brains used for vaccination, the dilution of virus that killed 50 per cent or more of the unvaccinated animals was designated as one M.L.D. of the challenge virus. If 50 per cent or more of the vaccinated animals survived ten, one hundred or one thousand times this concentration of virus, the mice were said to be protected against 10, 100 or 1000 intracerebral M.L.D.'s.
The virus titers of the infected brains used for the vaccinating doses varied from 10-1 to 10-7, the majority of them testing 10-6. Two strains, S-7 and S-16, were so low in titer on the second mouse passage that it was necessary to repeat the tests on third passage material. A third strain, S-6, was so highly infectious by the in-BET1'YLEE HAMPIL AND G. H. ROBERTS traperitoneal route that several tests were made diluting the virus 10-3, 10-i, and 10-' for the intraperitoneal injections. This strain also produced a high titer in mouse brains (the 10-, dilution regularly killing all the injected animals).
RESULTS
The results obtained from a single test on each of the virus strains are given in detail in There are three strains that produce a good immunity against 10 to 100 M.L.D.'s: two of these are Pasteur substrains, the third is the R-1 strain. And, finally, we have a group of substrains from the Pasteur strain that produce an immunity against 100 + to 1000 or more intracerebral M.L.D.'s. All four strains have been procured from Paris within the last three years. At the 44BEI'TYLEE HAMPIL AND G. H. ROBERTS time the tests were made we were unaware of the identity of two of them, S-5 and S-9. S-9 was obtained from the Pasteur Institute by Dr. Habel. It came to us in rabbit brain and was tested in the second mouse passage. S-16 was sent to us by Dr. Ramon, and was tested in the third mouse passage. S-5 was also secured from Dr. Habel. It had been sent to him by Dr. Webster in the fifteenth mouse passage, was passed twice before we received it, and was tested by us in the eighteenth and nineteenth passages. And finally there is the S-15 strain which was obtained directly from Dr. MWebster in its 52nd mouse passage and was passed twice before being used for the tests. Thus tests have been made on the third, the eighteenth and the fifty-fourth mouse passage of the same virus with practically identical results. Such results can scarcely be attributed either to chance or to species adaptation of the virus and further serve to fortify the validity of the low values obtained with the other virus strains.
DISCUSSION
The results of the experiments reported in this investigation give rise to considerable speculative thought and present a challenge to study more precisely the fundamental character of rabies viruses as well as rabies immunity. Casals and Webster (1940) had reported that a vaccinating dose of 16,000 lethal doses immunized 21-day old mice against a maximum of 100 intracerebral doses. It therefore came as a distinct surprise in the early part of the work to find that, in the case of some of the virus strains, groups of mice could be injected intraperitoneally with a quantity of living virus sufficiently large to cause death from rabies of one quarter or more of the animals injected and yet that the survivors were not solidly immune to as little as one intracerebrally injected lethal dose of the homologous virus.
Differences in the clinical manifestations, infectivity and virulence of strains of street virus are well recognized. Likewise, it has been reported that vaccines prepared from various strains of fixed virus are not equally effective as antigens; the Pasteur Institute (Paris) strain is generally conceded to be a better antigen than others used (Van Rooyen and Rhodes, 1941 (Webster, 1938) of the Swiss mouse as a convenient and reliable laboratory test animal. The data presented in this paper suggest that the immunological problems connected with homologous immunity may also be more complex than has been anticipated and that the same strain of fixed virus may become so altered under different environmental conditions that its intrinsic immunogenic properties are diminished or changed. For example, strains S-2, S-11, S-13 and S-14, classified by us as weakly antigenic, are all substrains of the original Pasteur virus, carried in four laboratories over a period of many years. Cross protection tests with one of the highly antigenic Pasteur substrains (S-15 or S-16) may help to determine how profound this alteration may actually be. It would also be of interest to determine whether the strains we have classified as weakly antigenic (in so far as they fail to immunize significantly against homologous virus injected intracerebrally) are also weak antigens for the production of serum neutralizing antibodies. Information on these points will be reported in a later paper.
It should be emphasized that the differences detected in our experiments would probably be obscured under less rigid experimental conditions. Unusual care was taken in the selection of the mice employed, animals exactly 21 or 22 days old being used throughout. Casals and Webster (1940) and Casals (1940) have reported that 60-day-old W-Swiss mice are more readily immunized to virulent virus than 20-day-old or younger mice. Habel (1940) found that two-months-old mice were immunized more readily with phenolized vaccines than one-month-old mice. Wyckoff and Tesar (1940) Invariably the three older age groups exhibit 100 to 1000 fold superior immunity to the 21-day old animals. The practical application of these studies may not be without significance in the preparation of rabies vaccines. The use of mice in the weeding out of non-antigenic vaccines is now an established procedure. It seems reasonable to predict that, other things being equal, a vaccine prepared from a strain possessing high intrinsic immunogenic properties as a living virus may show superior antigenic potency to a vaccine prepared from a strain less immunogenic as a living virus when the homologous strain is used as the challenge virus. It also seems not unreasonable to predict that killed vaccines prepared from a highly immunogemc strain will produce on repeated administration a greater degree of immunity to heterologous strains than those prepared from strains possessing low intial immunogenic properties. Studies along these lines are being continued.
SUMMARY
Seventeen strains of fixed rabies virus have been investigated with respect to their immunogenic properties as virulent vaccines in 21-day-old Swiss mice. Immunity was tested by intracerebral injection of homologous virus. The results indicate that wide differences occur in the immunity response of the mice depending upon the strain of virus employed. Four substrains of the Pasteur virus obtained from Paris since 1938 appear to possess intrinsic immunizing properties superior to the other strains tested. The immunological and practical significance of the results is discussed.
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